SCHEMBL3887598

SCHEMBL3887598

Nc1cc(CCC(=O)O)cc(-c2ccc3ccccc3c2)c1OC1Cc2ccccc2C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 7/20 0.47
CCNC P24863 1/20 0.43
CDK8 P49336 1/20 0.43
FFAR1 O14842 4/20 0.38
THRA P10827 1/20 0.38
THRB P10828 1/20 0.38
CYP1A2 P05177 1/20 0.38
NR1H2 P55055 1/20 0.36
NR1H3 Q13133 1/20 0.36
PTGES O14684 1/20 0.36
ALOX5 P09917 1/20 0.36
S1PR5 Q9H228 2/20 0.35
PDE4A P27815 2/20 0.35
PDE4B Q07343 2/20 0.35
PDE4C Q08493 2/20 0.35
PDE4D Q08499 2/20 0.35
PLA2G10 O15496 1/20 0.35
PLA2G2A P14555 1/20 0.35
SLCO1B1 Q9Y6L6 1/20 0.35
S1PR4 O95977 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3888617 0.89 CCNC (0.47) FFAR4CCNCCDK8PDE4APDE4B
SCHEMBL3689057 0.89 THRA (0.51) FFAR4CCNCCDK8FFAR1THRA
SCHEMBL3882484 0.88 THRA (0.53) FFAR4CCNCCDK8FFAR1THRA
SCHEMBL3883583 0.88 ENPP2 (0.40) FFAR4FFAR1THRATHRB
SCHEMBL3882504 0.86 FFAR4 (0.45) FFAR4CCNCCDK8FFAR1THRA
SCHEMBL3885656 0.86 FFAR4 (0.45) FFAR4CCNCCDK8FFAR1THRA
SCHEMBL923645 0.86 TRPA1 (0.41) FFAR4
SCHEMBL3887162 0.85 FFAR4 (0.39) FFAR4CCNCCDK8NR1H2NR1H3
SCHEMBL3885078 0.84 FFAR4 (0.44) FFAR4CCNCCDK8FFAR1THRA
SCHEMBL3881647 0.84 AKR1C3 (0.39) FFAR1S1PR5PDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1477472-B1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF ASAHI KASEI PHARMA CORP (JP) 2009-01-14 EP claimed
US-6867320-B2 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2005-03-15 US claimed
EP-1477472-A1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF Asahi Kasei Pharma Corporation (JP) 2004-11-17 EP claimed
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2004-03-04 US claimed
EP-1477472-B1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF ASAHI KASEI PHARMA CORP (JP) 2009-01-14 EP disclosed
US-6867320-B2 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2005-03-15 US disclosed
EP-1477472-A1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF Asahi Kasei Pharma Corporation (JP) 2004-11-17 EP disclosed
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2004-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof PTGER1, CYSLTR1, PTGS1 FFAR4 115/4885CCNC 2174/4885CDK8 3600/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.